Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection

Journal of Hepatology

Volumn 56, Issue 6, 2012, Pages 1259-1268

  Harfouch, Sawsan ^a,b   Guiguet, Marguerite ^a,b   Valantin, Marc Antoine ^a   Samri, Assia ^a,b   Ouazene, Zineb ^c   Slama, Laurence ^d   Dominguez, Stéphanie ^e   Simon, Anne ^a   Theodorou, Ioannis ^a,b   Thibault, Vincent ^a   Autran, Brigitte ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d HÔPITAL TENON   (France)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

Anti HCV treatment; Immunosuppressive cytokine; Predictive marker; Spontaneous recovery; Sustained virologic response

Indexed keywords

INTERLEUKIN 28B; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; NONHUMAN; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT FAILURE; TREATMENT RESPONSE; VIRAL CLEARANCE; VIREMIA;

ACUTE DISEASE; COINFECTION; GENOTYPE; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; POLYMORPHISM, GENETIC; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84861199609     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.01.021     Document Type: Article

References (52)

1. D.L. Thomas, C.L. Thio, M.P. Martin, Y. Qi, D. Ge, and C. O'Huigin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
2. H.L. Tillmann, A.J. Thompson, K. Patel, M. Wiese, H. Tenckhoff, and H.D. Nischalke A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice Gastroenterology 139 2010 1586 1592 e1581
3. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
4. C. Sarrazin, S. Susser, A. Doehring, C.M. Lange, T. Muller, and C. Schlecker Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients J Hepatol 54 2011 415 421
5. Stattermayer AF, Stauber R, Hofer H, Rutter K, Beinhardt S, Scherzer TM, et al. Impact of IL28B genotype on the early and sustained virologic response in treatment-naive patients with chronic hepatitis C. Clin Gastroenterol Hepatol.
6. A. Mangia, A.J. Thompson, R. Santoro, V. Piazzolla, H.L. Tillmann, and K. Patel An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response Gastroenterology 139 2010 821 827 e821
7. F. Lechner, D.K. Wong, P.R. Dunbar, R. Chapman, R.T. Chung, and P. Dohrenwend Analysis of successful immune responses in persons infected with hepatitis C virus J Exp Med 191 2000 1499 1512 (Pubitemid 30257347)
8. R. Thimme, D. Oldach, K.M. Chang, C. Steiger, S.C. Ray, and F.V. Chisari Determinants of viral clearance and persistence during acute hepatitis C virus infection J Exp Med 194 2001 1395 1406 (Pubitemid 33081515)
9. N.H. Gruner, T.J. Gerlach, M.C. Jung, H.M. Diepolder, C.A. Schirren, and W.W. Schraut Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C J Infect Dis 181 2000 1528 1536 (Pubitemid 30387741)
10. H. Wedemeyer, X.S. He, M. Nascimbeni, A.R. Davis, H.B. Greenberg, and J.H. Hoofnagle Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection J Immunol 169 2002 3447 3458 (Pubitemid 35013196)
11. D.E. Kaplan, F. Ikeda, Y. Li, N. Nakamoto, S. Ganesan, and M.E. Valiga Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis J Hepatol 48 2008 903 913
12. A.J. MacDonald, M. Duffy, M.T. Brady, S. McKiernan, W. Hall, and J. Hegarty CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons J Infect Dis 185 2002 720 727 (Pubitemid 34226199)
13. D. Accapezzato, V. Francavilla, M. Paroli, M. Casciaro, L.V. Chircu, and A. Cividini Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection J Clin Invest 113 2004 963 972 (Pubitemid 38544117)
14. M.T. Brady, A.J. MacDonald, A.G. Rowan, and K.H. Mills Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes Eur J Immunol 33 2003 3448 3457 (Pubitemid 37541123)
15. N. Alatrakchi, C.S. Graham, H.J. van der Vliet, K.E. Sherman, M.A. Exley, and M.J. Koziel Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses J Virol 81 2007 5882 5892 (Pubitemid 46847025)
16. A.G. Rowan, J.M. Fletcher, E.J. Ryan, B. Moran, J.E. Hegarty, and C. O'Farrelly Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta J Immunol 181 2008 4485 4494
17. L. Cosmi, R. De Palma, V. Santarlasci, L. Maggi, M. Capone, and F. Frosali Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor J Exp Med 205 2008 1903 1916
18. J.W. Northfield, V. Kasprowicz, M. Lucas, N. Kersting, B. Bengsch, and A. Kim CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation Hepatology 47 2008 396 406 (Pubitemid 351280707)
19. E. Billerbeck, Y.H. Kang, L. Walker, H. Lockstone, S. Grafmueller, and V. Fleming Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties Proc Natl Acad Sci USA 107 2010 3006 3011
20. P. Burra, A. Masier, F. Morisco, V. Di Leo, M. Zorzi, and M. Senzolo HCV infection in haemodialysed patients: a role for serum IL-10 and TGF-beta1 in liver damage? Dig Liver Dis 40 2008 827 833
21. S. Lee, J. Varano, J.P. Flexman, W. Cheng, M.W. Watson, and E. Rossi Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus Dis Markers 28 2010 273 280
22. J. Nattermann, M. Vogel, H.D. Nischalke, M. Danta, G. Ahlenstiel, and M. Michalk The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C AIDS 22 2008 1287 1292
23. L.E. Wilson, M. Torbenson, J. Astemborski, H. Faruki, C. Spoler, and R. Rai Progression of liver fibrosis among injection drug users with chronic hepatitis C Hepatology 43 2006 788 795
24. W. Lin, W.L. Tsai, R.X. Shao, G. Wu, L.F. Peng, and L.L. Barlow Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner Gastroenterology 138 2010 2509 2518 e2501
25. L.D. Presser, A. Haskett, and G. Waris Hepatitis C virus-induced furin and thrombospondin-1 activate TGF-beta1: role of TGF-beta1 in HCV replication Virology 412 2011 284 296
26. J.Y. Shin, W. Hur, J.S. Wang, J.W. Jang, C.W. Kim, and S.H. Bae HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1 Exp Mol Med 37 2005 138 145 (Pubitemid 40676924)
27. D. Sene, F. Levasseur, M. Abel, M. Lambert, X. Camous, and C. Hernandez Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines PLoS Pathog 6 2010 e1001184
28. G.M. Lauer, and B.D. Walker Hepatitis C virus infection N Engl J Med 345 2001 41 52 (Pubitemid 32634271)
29. M.S. Sulkowski, and D.L. Thomas Hepatitis C in the HIV-infected person Ann Intern Med 138 2003 197 207 (Pubitemid 36231625)
30. M.V. Ragni, and S.H. Belle Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection J Infect Dis 183 2001 1112 1115 (Pubitemid 32230961)
31. C.S. Graham, L.R. Baden, E. Yu, J.M. Mrus, J. Carnie, and T. Heeren Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis Clin Infect Dis 33 2001 562 569 (Pubitemid 32709592)
32. A.Y. Kim, J. Schulze zur Wiesch, T. Kuntzen, J. Timm, D.E. Kaufmann, and J.E. Duncan Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection PLoS Med 3 2006 e492
33. M. Danta, N. Semmo, P. Fabris, D. Brown, O.G. Pybus, and C.A. Sabin Impact of HIV on host-virus interactions during early hepatitis C virus infection J Infect Dis 197 2008 1558 1566 (Pubitemid 351706486)
34. G. Harcourt, E. Gomperts, S. Donfield, and P. Klenerman Diminished frequency of hepatitis C virus specific interferon gamma secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients Gut 55 2006 1484 1487 (Pubitemid 44476795)
35. V. Dutoit, D. Ciuffreda, D. Comte, J.J. Gonvers, and G. Pantaleo Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV coinfection Eur J Immunol 35 2005 3493 3504 (Pubitemid 43025531)
36. H. Valdez, D. Anthony, F. Farukhi, A. Patki, J. Salkowitz, and P. Heeger Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients AIDS 14 2000 2239 2246
37. A. Schnuriger, S. Dominguez, M. Guiguet, S. Harfouch, A. Samri, and Z. Ouazene Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus AIDS 23 2009 2079 2089
38. G.M. Lauer, T.N. Nguyen, C.L. Day, G.K. Robbins, T. Flynn, and K. McGowan Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses J Virol 76 2002 2817 2826 (Pubitemid 34184868)
39. N.I. Rallon, S. Naggie, J.M. Benito, J. Medrano, C. Restrepo, and D. Goldstein Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients AIDS 24 2010 F23 F29
40. J.A. Pineda, A. Caruz, A. Rivero, K. Neukam, I. Salas, and A. Camacho Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus Clin Infect Dis 51 2010 788 795
41. J. Nattermann, M. Vogel, H.D. Nischalke, M. Danta, S. Mauss, and H.J. Stellbrink Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C J Infect Dis 203 2011 595 601
42. G. Bellone, M. Aste-Amezaga, G. Trinchieri, and U. Rodeck Regulation of NK cell functions by TGF-beta 1 J Immunol 155 1995 1066 1073
43. W. Lin, E.M. Weinberg, A.W. Tai, L.F. Peng, M.A. Brockman, and K.A. Kim HIV increases HCV replication in a TGF-beta1-dependent manner Gastroenterology 134 2008 803 811 (Pubitemid 351312737)
44. J.T. Blackard, L. Smeaton, Y. Hiasa, N. Horiike, M. Onji, and D.J. Jamieson Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons J Infect Dis 192 2005 258 265 (Pubitemid 40993395)
45. A. Takaki, M. Wiese, G. Maertens, E. Depla, U. Seifert, and A. Liebetrau Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C Nat Med 6 2000 578 582 (Pubitemid 30305910)
46. Lunge VR, da Rocha DB, Beria JU, Tietzmann DC, Stein AT, Simon D. IL28B polymorphism associated with spontaneous clearance of hepatitis C infection in a southern Brazilian HIV type 1 population. AIDS Res Hum Retroviruses.
47. J.A. Pineda, A. Caruz, F.A. Di Lello, A. Camacho, P. Mesa, and K. Neukam Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients Aids 25 2011 1415 1420
48. T. Boettler, H.C. Spangenberg, C. Neumann-Haefelin, E. Panther, S. Urbani, and C. Ferrari T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection J Virol 79 2005 7860 7867 (Pubitemid 40756821)
49. R. Cabrera, Z. Tu, Y. Xu, R.J. Firpi, H.R. Rosen, and C. Liu An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection Hepatology 40 2004 1062 1071 (Pubitemid 39425561)
50. K. Sugimoto, F. Ikeda, J. Stadanlick, F.A. Nunes, H.J. Alter, and K.M. Chang Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection Hepatology 38 2003 1437 1448 (Pubitemid 37466970)
51. S.M. Rushbrook, S.M. Ward, E. Unitt, S.L. Vowler, M. Lucas, and P. Klenerman Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection J Virol 79 2005 7852 7859 (Pubitemid 40756820)
52. Rallon NI, Barreiro P, Soriano V, Garcia-Samaniego J, Lopez M, Benito JM. Elevated TGF-beta1 levels might protect HCV/HIV-coinfected patients from liver fibrosis. Eur J Clin Invest 41:70-76.